Market Access · Strategy
Market Access Strategy
A market access strategy is the plan that turns a promising treatment into a funded one, built on a clear value story and the evidence to prove it.
The evidence that powers modern access strategy is a central theme at RWE Connect 2026 in Boston.
Free. Instant download. No obligation.
The definition
What a Market Access Strategy Is
A market access strategy is the plan for securing and defending coverage, reimbursement and appropriate use of a treatment. It aligns the value story, the evidence, the price and the people who need to be convinced into one coherent approach.
It is how the broad discipline of market access becomes a concrete plan for a specific product, and it increasingly runs on real-world evidence.
The components
The Pillars of a Market Access Strategy
A complete strategy rests on a handful of connected pillars. Neglect one and the whole plan is weaker for it.
How to build one
Building the Strategy, Step by Step
A strong strategy is built in a logical order, each step setting up the next.
The RWE engine
The Role of Real-World Evidence
Real-world evidence has moved from a nice-to-have to the engine of access strategy. It is where a modern value story is won or lost, a core theme at RWE Connect 2026.
What goes wrong
Strategic Pitfalls to Avoid
Most access failures trace back to a handful of avoidable mistakes. Knowing them is half the battle.
The direction of travel
Where Access Strategy Is Heading in 2026
Access strategy is being reshaped by real-world evidence, earlier engagement and new contracting models. These are the shifts on the agenda at RWE Connect 2026.
Who is in the room
Who Attends RWE Connect 2026
A senior, focused audience of the people who build and execute access strategy.
Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.
Explore
Explore Related Topics
Strategy is where evidence, economics and payer insight come together.
Sponsor RWE Connect 2026
Meet the Access Strategists in Boston
The teams that build and run access strategy gather at RWE Connect 2026: 150+ attendees, around 60% at Director or VP level and above.
RWE Connect 2026
Get the RWE Pipeline Report 2026
See the evidence trends reshaping how access strategy is built, then meet the strategists in Boston.
- How RWE now drives strategy
- What a strong value story needs
- Where access strategy is heading
Free. Instant download. No obligation.
Market Access Strategy: Common Questions
What is a market access strategy?
A market access strategy is the plan for securing and defending coverage, reimbursement and appropriate use of a treatment, built around a clear value story and the evidence needed to prove it to payers.
Why is a market access strategy important?
Without a strategy, even an effective treatment can fail to reach patients. A good strategy aligns evidence, pricing and stakeholder engagement so access is secured efficiently and defended over time.
What are the components of a market access strategy?
A value story, an evidence plan, a pricing and reimbursement approach, payer segmentation, stakeholder engagement, and a launch and lifecycle plan.
How do you build a market access strategy?
Understand the landscape, define the value story, plan the evidence, set pricing and access goals, map stakeholders, and execute while adapting to real-world feedback.
When should you start planning market access?
As early as possible, ideally years before launch, so the evidence needed to prove value can be built into the clinical and real-world data plan.
What is the role of real-world evidence in access strategy?
Real-world evidence demonstrates value, fills evidence gaps, strengthens pricing, enables value-based deals and defends access after launch, making it central to modern strategy.
What is payer segmentation?
Grouping payers by their priorities, evidence needs and decision processes, so the strategy can be tailored rather than treating all payers the same.
What is a value story?
The clear, evidence-backed narrative of the clinical, economic and patient value a treatment delivers, at the heart of any access strategy.
How is a market access strategy different from market access?
Market access is the broad discipline of securing reimbursement. A market access strategy is the specific plan a team builds to achieve it for a given product.
What are common market access strategy mistakes?
Planning access too late, a weak value story, treating all payers alike, underestimating payers, thin evidence, and having no plan to defend access after launch.
What is RWE Connect 2026?
RWE Connect 2026 is a two-day real-world evidence summit in Boston bringing together the RWE, HEOR and market access leaders who generate and apply real-world evidence, with 40+ speakers and 150+ attendees.
When and where is RWE Connect 2026?
14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.
